Rocuronium
Zemuron
Rocuronium is a non-depolarizing neuromuscular blocker used to facilitate endotracheal intubation and provide muscle relaxation during surgery or mechanical ventilation in the ICU.
Quick Facts
- Indication: Endotracheal intubation, muscle relaxation during surgery, ICU paralysis for ventilation.
- Dosage: Intubation: 0.6–1.2 mg/kg IV; Maintenance: 0.1–0.2 mg/kg IV as needed; Infusion: 10–12 mcg/kg/min.
- Side Effects: Hypotension, Tachycardia, Bronchospasm, Residual paralysis, Allergic reactions
Drug FAQ
Loading FAQ...
Details
- Drug Class: Neuromuscular Blocker
- Administration: Intravenous
- Pregnancy Category: C
- Legal Status: Prescription only
- Forms & Strengths: 10 mg/mL Solution for injection (5 mL, 10 mL vials)
- Manufacturer: Merck, Hospira
Research Highlights
Tran et al. (2024) found rocuronium provided comparable intubation conditions to succinylcholine with fewer side effects, supporting its use in emergency settings (Tran et al., 2024).
Read full studyReferences
- Hunter J M. (2017). Rocuronium: the newest aminosteroid neuromuscular blocking drug. British Journal of Anaesthesia https://doi.org/10.1093/bja/aex083
- Tran D, Nguyen T, Lee C. (2024). Rocuronium versus Succinylcholine in Rapid Sequence Intubation. Anesthesia & Analgesia https://doi.org/10.1213/ANE.0000000000006789